- All
- Blog
- Grants
- News
- Newsletter
- Publications
- Uncategorized
- Webinar
ToxTracker and its application for read-across
The chemical industry and the REACH deadline REACH is the European legislation for Registration, Evaluation and Authorisation of CHemicals. It requires that each manufacturer or importer of chemicals in the European Union handling chemicals in quantities of 1 metric ton or more per year, to demonstrate...
Toxys newsletter January 2018
Here you can view our newsletter from January 2018 [campaign id="5376962ead"]...
First official ToxTracker workshop during SOT 2018
You are cordially invited to join the first official ToxTracker workshop during the SOT 2018 meeting in San Antonio. The workshop provides a unique opportunity to learn more about the ToxTracker reporter assay for cancer hazard assessment. We will update you on the latest developments...
Toxys and Omnigen receive MIT grant to develop Toxplot software for animal-free chemical safety testing.
4 January 2018 - Toxys and Omnigen have received a MIT grant for the development and extension of the ToxPlot software. With this grant, the ToxPlot analysis tool will be further developed to allow quantitative and hypothesis-free toxicity profiling of novel chemicals. Currently, ToxPlot is...
Toxys has been awarded Innovation Credit to further develop ReproTracker
Leiden 20 September 2017 - Today Toxys was awarded an Innovation Credit from RVO to accelerate the develop of the ReproTracker assay. ReproTracker® is a state-of-the-art in vitro reporter assay to rapidly identify compounds that disturb stem cell differentiation and early embryonic development. Testing for...
European patent for ToxTracker granted
6 July 2017 - Leiden, the Netherlands - Toxys is proud to announce that next to the US patent which already was granted, the European patent for ToxTracker, an unique genotoxicity assay, has been granted. About ToxTracker ToxTracker® assay is a state-of-the-art stem cell-based reporter assay that...
ToxTracker is featuring in the upcoming Springer Nature Webinar on Wednesday the 14th of June
Toxys presents in collaboration with Millipore, the ToxTracker assay as an innovative in vitro system for cancer hazard assessment that provides detailed insight into the mode of action of genotoxic compounds. Click here for more information ...
Toxys newsletter May 2017
Here you can view the newsletter May 2017 [campaign id="48084b7c39"]...
Toxys launches large international validation study for ToxTracker
Leiden, 1 May 2017 - Together with a consortium of leading experts in the field of genotoxicity, Toxys has started a large inter-laboratory validation study for their ToxTracker assay. With this study, Toxys aims to demonstrate the transferability, intra- and inter-laboratory reproducibility as well as...
ToxTracker included in webinar by Charles River: Avoid Program Set-Backs: Deciphering Positive Reponses
In a webinar on genetic toxicology by Charles River the ToxTracker assay was included. Via this link you can view the webinar, the information on ToxTracker starts at 38 minutes. ...
Toxys is part of organising committee for workshop: Mode of Action Approaches That Identify Genotoxic Mechanisms in Mammalian Cell Systems (May 10th 2017)
The HESI Genetic Toxicology Technical Committee (GTTC) will hold the workshop in conjunction with the Genetic Toxicology Association (GTA) annual meeting on 10 May 2017 in Newark, Delaware. The first part of the workshop is intended to establish key cellular and genetic events for defined...
Interview with Toxys CEO Giel Hendriks and cover spread in TerugbliQ – the year report from Innovation Quarter
In TerugbliQ, the year report from Innovation Quarter you can read an interview with our CEO Giel Hendriks (in Dutch), please click here for the year report and the interview...
Poster together with Concawe presented at the SOT 2017: Use of ToxTracker for Petrochemical products
The goal of this project was to investigate whether the ToxTracker assay can be applied to petroleum UVCBs as a high-content screen for mutagenicity / carcinogenicity by testing by testing twelve DMSO extracts of petroleum substances for (geno)toxic properties in the assay. Conclusions: The ToxTracker assay...
Poster together with P&G presented at the SOT 2017: use of multiparametric mode of action approaches for genetic toxicity assessment
This poster describes the investigation of several different predictive, animal-free genetic toxicology methodologies with varying degrees of complexity. The predictive capacity of these methods was compared by testing 22 chemicals that represent a mix of DNA reactive chemicals, chemicals with known, mixed or unknown modes...
Toxys mentioned as top-10 biotech in Leiden
In this article by Labiotech.eu Toxys is mentioned as one of the top-10 biotech companies in Leiden. Stroopwaffels, Krokets and Biotechs – Meet the Top 10 in Leiden! ...
Toxys newsletter February 2017
You can find our Newsletter here: [campaign id="4be8da4c89"]...
ToxTracker – the better genotoxicity assay
This is the first blog in a series to come to share what we are doing at Toxys and to inspire you. Toxys provides innovative in vitro toxicity screening solutions to rapidly identify hazardous and potential carcinogenic properties of novel compounds during the early phases...
Toxys newsletter November 2016
Here you can view our newsletter November 2016 [campaign id="9bd924d332"]...
Toxys awarded € 50.000 by EIT Health to develop ReproTracker – an in vitro assay for reproductive toxicity
21 September 2016 - Today Toxys was awarded a €50.000 grant for a head-start project to further develop the ReproTracker. Toxys is dedicated to develop innovative in vitro toxicity assays that provide insight into the mechanisms of toxicity. Toxys' lead product ToxTracker is a genotoxicity...
ToxTracker, the future for genotoxicity screening of nanoparticles
Many of the traditional genotoxicity test methods [e.g. unscheduled DNA synthesis assay, bacterial reverse mutation (Ames) test, etc.,] for determining the DNA damaging potential of chemical and biological compounds are not suitable for the evaluation of engineered nanomaterials (ENMs), due to a variety of methodological...
